Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[califax]

whats the date for the fda approval (2)

Quarterly Report (10-Q)

http://ih.advfn.com/p.php?pid=nmona&article=43941581&symbol=A^CXM

We also entered into a multi-year supply agreement with Devro Medical Limited, part of Devro plc, a public limited company registered in Scotland, for the supply of highly-refined fibrillar bovine Type I collagen, an important component of our new Excellagen formulated collagen product candidate, which is pending FDA 510(k) clearance. Under this supply agreement, the collagen component of Excellagen will be manufactured at Devro's new cGMP manufacturing facility which is currently undergoing final process validation activities and awaiting a formal accreditation audit for ISO certifications. Devro also plans to establish a Device Master File with the FDA following completion of ISO certifications of other component manufacturing processes. In addition, we have also entered into a clinical manufacturing and supply agreement with Devro’s U.S.-based fill and finish contract manufacturer to provide final processing and assembly of the market ready Excellagen product.